This is the authors' abstract. We don't add key points for this paper.
Magnesium sulfate has neuroprotective effects and decrease overall neuronal firing. It is also decrease firing of excitable tissues outside the brain. We study the anti-inflammatory and antioxidant effects of magnesium sulfate in rat brain following ischemia reperfusion (I/R) stress. Twenty four rats were grouped into 4 groups: The first (sham group), the second (control) and the third group(control-vehicle) and the forth (treated with Magnesium sulfate). Animals in the second group underwent bilateral common carotid artery ligation without treatment, whereas the forth group were injected with magnesium sulfate 250mg/kg intraperitoneally before procedure. Brain homogenate were prepared after the procedure for measurement of cerebral level of IL-6, IL-9, MCP-1 and ICAM. Cerebral level of IL-9 in control group was 163.3 ± 30.4 pg/mg and it significantly decreased in magnesium sulfate treated group (21.8 ± 1.72 pg/mg). Cerebral level of MCP-1 in the control group was 109.05 ± 18.2 pg/mg, while it significantly reduced in magnesium sulfate treated group (38.16 ± 3.54 pg/mg). Mean cerebral levels of ICAM of control was 362.8 ± 26.81 pg/mg while mean cerebral level of ICAM in treated group was 35.5 ± 4.71 pg/mg. We concluded that magnesium sulfate significantly decreasedcerebral inflammatory markers IL-6, IL-9, MCP-1 and ICAM in global ischemia model in rats and regressed I/R injury
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hadi et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: